Secora Michaelinsider trades
In SEC Form 4 filings, Secora Michael is listed as CFO & Chief Corp Dev Ofcr of Iambic Therapeutics, Inc. (IAM). Secora Michael reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Oct 19.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| IAMIambic Therapeutics, Inc. | CFO & Chief Corp Dev Ofcr | 4 | Oct 19 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-10-16
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| IAMIambic Therapeutics, Inc. | Oct 16 | Oct 19 | C | 61,342 | not reported | not reported | 279,902 | No | Form 4 |
| IAMIambic Therapeutics, Inc. | Oct 16 | Oct 19 | C · derivative | 61,342 | $0.00 | $0 | not reported | No | Form 4 |
| IAMIambic Therapeutics, Inc. | Oct 14 | Oct 16 | A | 28,400 | $0.00 | $0 | 218,560 | No | Form 4 |
| IAMIambic Therapeutics, Inc. | Oct 14 | Oct 16 | A · derivative | 170,300 | $16.00 | $2,724,800 | 170,300 | No | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.